Astrazeneca Share News (AZN)
AZN Share
AZN Share
AZN Share
AZN Share
AZN
AZN Share
AZN Level 2
AZN Live
AZN Broker
AZN Directors
AZN Financial
AZN
AZN Short
AZN
Last checked at -
(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window)* Vodafone among top FTSE 100 gainers* Recruiter SThree gains after annual profit doubles* Online estate agency Purplebricks forecasts growth...
Read more(Adds detail, AstraZeneca comment, paragraphs 7,8)BEIJING, Jan 29 (Reuters) - Chinese authorities summoned officials of AstraZeneca China regarding an investigation of suspected medical insurance fraud by the company's employees, the National Heal...
Read more
LONDON BROKER RATINGS: Credit Suisse likes Hargreaves Lansdown, abrdn
Read moreBERLIN, Jan 25 (Reuters) - Germany expects to receive 3.8 million doses of Novavax's newly approved COVID-19 vaccine Nuvaxovid by March 20, the health ministry said on Tuesday, as the government looks to persuade unvaccinated Germans to get a sho...
Read moreJan 24 (Reuters) - A panel of the European drug regulator on Monday approved scaling up manufacturing of AstraZeneca's COVID-19 vaccine.An existing manufacturing site operated by Universal Farma in Guadalajara, Spain, will add a second filling lin...
Read more
(Sharecast News) - Analysts at Morgan Stanley sounded a 'bullish' note on the outlook for the FTSE 100, highlighting its greater 'defensive' properties relative to rivals, higher dividend yields versus global peers, exposure to energy and record low expectations for growth in the profits of its constituent companies.
Read moreAstraZeneca Imfinzi's shows positive results in liver cancer treatment
Read more(Sharecast News) - AstraZeneca on Wednesday said its Imfinzi drug combined with chemotherapy reduced the risk of death by 20% in people with advanced biliary tract cancer (BTC) after results from a phase III clinical trial.
Read moreAstraZeneca posts robust results for Imfinzi as tract cancer treatment
Read more* Pharma groups have been working on upgraded Omicron vaccines* BioNTech CEO has questioned merit of multipurpose shot (Adds background, BioNTech remarks)By Ludwig Burger and Pushkala AripakaJan 18 (Reuters) - The European Union drugs regulator sai...
Read more(Sharecast News) - Drugmaker AstraZeneca said on Monday that its Daiichi Sankyo collaboration Enhertu had been granted priority review by the Federal Drug Administration in the US for patients with HER2-positive metastatic breast cancer treated with a prior anti-HER2-based regimen.
Read moreTOP NEWS: New AstraZeneca vaccine results show strong effect on Covid
Read moreLONDON BRIEFING: AIM giant ASOS to move to London Main Market
Read more(Adds context on other trials and studies)By Pushkala Aripaka and Ludwig BurgerJan 13 (Reuters) - AstraZeneca said on Thursday that preliminary data from a trial showed that its COVID-19 shot, Vaxzevria, generated an increase in antibodies against ...
Read more(Adds detail from study, background)Jan 13 (Reuters) - AstraZeneca said on Thursday preliminary data from a trial it conducted on its COVID-19 shot, Vaxzevria, showed it generated a higher antibody response against the Omicron variant and others, ...
Read more
Last checked at